Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 16 days · First seen 29 days ago · Last updated 13 days ago

Drägerwerk financial performance trends

Overview

In mid-October 2026, Drägerwerk shares fell nearly 15 percent following preliminary quarterly results that showed a decline in EBIT to 48 million euros from 56.7 million euros the previous year. The EBIT margin also dropped from 6.8 percent to 5.6 percent. Analysts noted that the results included 20.1 million euros in customs refunds, without which the operating margin would have been 3.3 percent. Despite this, management maintained full-year guidance, citing an 8.2 percent increase in orders, particularly in safety technology.

By late October 2026, the company reported increased earnings for the first nine months of the year. Net sales rose to approximately 2,454 million euros, an increase of 110 million euros compared to 2025. EBIT for this period rose to 111.8 million euros, up from 77.1 million euros the previous year, supported by strong operating performance and U.S. customs refunds. Order intake also grew to approximately 2,674 million euros.

Entities

Germany · Drägerwerk AG & Co. KGaA · Drägerwerk · MWB Research · United States

Claims

What the coverage asserts, and how many sources carry each claim.

[● 2 SOURCES] Grammer AG group revenue increased by 3.5 percent to EUR 1,435.6 million in the first nine months of 2026.
[● 2 SOURCES] Grammer AG revenue in the APAC region grew by 13.6 percent to EUR 408.6 million.
[● 2 SOURCES] Grammer AG adjusted 2026 outlook projects revenue of approximately EUR 1.9 billion.
[○ 1 SOURCE] Drägerwerk AG & Co. KGaA net sales rose to approximately EUR 2,454 million in the first nine months of 2026.
[○ 1 SOURCE] Drägerwerk AG & Co. KGaA EBIT increased to EUR 111.8 million in the first nine months of 2026.
[○ 1 SOURCE] Drägerwerk AG & Co. KGaA EBIT included one-off effects from U.S. customs refunds.
[○ 1 SOURCE] Drägerwerk AG & Co. KGaA order intake increased to approximately EUR 2,674 million.
[○ 1 SOURCE] Germany was the largest growth driver for Drägerwerk with a 15 percent increase.

Timeline

13 days ago

[BUSINESS] 4 sources
Grammer AG and Drägerwerk report increased earnings for first nine months of 2026
Grammer AG and Drägerwerk report higher revenues and earnings for the first nine months of 2026, driven by regional growth and improved operating performance.
29 days ago

[BUSINESS] 8 sources
Drägerwerk shares drop following weak quarterly operating results
Drägerwerk shares fell nearly 15 percent after weak quarterly EBIT results, though management maintained full-year guidance and reported strong order growth in safety technology.

Sources

ad-hoc-news.de · biotech-investments.com · finanzen.at · finanzen.ch